Physician

Howard Jay Kaplan, MD

According to 2025 Medicare claims, Howard Kaplan, MD (NPI: 1134224702) practices ophthalmology in the Kiryas Joel-Poughkeepsie-Newburgh, NY market, with the plurality of this provider's patient population coming from Dutchess, NY. Kaplan uses personal NPI as billing NPI and primary practice location at 12601-3942.

Kaplan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 681 traditional Medicare patients, billed 8,289 HCPCS/CPT codes, and received $2,017,279 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 295 prescription claims across 67 beneficiaries totaling $24,126 in drug costs, led by Loteprednol Etabonate (Loteprednol Etabonate). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have declined steadily, from $26,920 to $24,126. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.5M$3.0M2015 Medicare payment: $2,756,217 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,471,936 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,519,616 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,532,509 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,993,334 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,527,627 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,449,686 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,322,585 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,976,308 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,017,279 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,18710,559$2,756,217
20161,19110,516$2,471,936
20171,24610,876$2,519,616
20181,2219,916$2,532,509
20191,24110,882$2,993,334
20209558,459$2,527,627
20218498,242$2,449,686
20228687,838$2,322,585
20237757,109$1,976,308
20246818,289$2,017,279

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$18K$36K2015 Drug cost: $26,920 (USD; Tot_Drug_Cst)2016 Drug cost: $29,846 (USD; Tot_Drug_Cst)2017 Drug cost: $36,244 (USD; Tot_Drug_Cst)2018 Drug cost: $35,513 (USD; Tot_Drug_Cst)2019 Drug cost: $29,568 (USD; Tot_Drug_Cst)2020 Drug cost: $19,825 (USD; Tot_Drug_Cst)2021 Drug cost: $14,169 (USD; Tot_Drug_Cst)2022 Drug cost: $23,242 (USD; Tot_Drug_Cst)2023 Drug cost: $16,371 (USD; Tot_Drug_Cst)2024 Drug cost: $24,126 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201576294$26,920
201684333$29,846
2017111536$36,244
201892424$35,513
201985407$29,568
202057209$19,825
202148189$14,169
202249217$23,242
202352199$16,371
202467295$24,126

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg2412,044$640
67028Injection of drug into eye3141,245$101
92014Established patient complete exam of visual system176179$92
92012Established patient problem focused exam of visual system4751,270$73
92134Imaging of retina5791,453$34

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Loteprednol EtabonateLoteprednol Etabonate47933$6,186
Prednisolone AcetatePrednisolone Acetate531,291$2,510
Atropine SulfateAtropine Sulfate17841$736
OfloxacinOfloxacin411,400$704
LatanoprostLatanoprost291,378$263

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Howard Jay Kaplan, MD?

Tedicare shows public-source Medicare data for Howard Jay Kaplan, MD (NPI 1134224702), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Howard Jay Kaplan, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Howard Jay Kaplan, MD?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Howard Jay Kaplan, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.